全球女性健康治疗市场：规模、研究和预测，按类型（传染病、妊娠、癌症），区域分析，2022-2029 年

2021 年全球女性保健药物市场价值约为 1513.3 亿美元，并将在 2022-2029 年预测期内以超过 10.0% 的增长率稳步增长。

旨在识别和增强女性健康的医疗程序、工具和服务被称为女性健康疗法。 由于女性慢性病发病率的增加以及对避孕药具的需求以防止意外怀孕等因素，女性健康治疗市场正在增长。 由于癌症和传染病的早期发现、与怀孕有关的困难以及强大的新药的出现，预计医疗成本上升也将进一步推动市场。

世界卫生组织报告称，2020 年将有 230 万女性被诊断出患有乳腺癌，高于 2012 年的 168 万。 此外，古特马赫研究所 2021 年 3 月的一篇研究文章估计，印度约有 240 万青春期女性希望避孕并需要现代避孕措施。 因此，癌症患病率的上升和对预防意外怀孕的避孕药具的需求正在推动市场增长。 此外，新药治疗意识的提高和新药治疗的引入以及女性传染病的高流行率正在推动市场的有利增长。 然而，女性健康疗法的高成本阻碍了整个 2022-2029 年预测期内的市场增长。

全球女性健康疗法市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于品牌产品的主导地位、目标人群的增加以及对产品开发活动的投资增加，亚太地区在收入方面占据了市场主导地位。 另一方面，由于老年人口和目标人口的增加、生物仿製药开发研究合作的增加、大公司的地域扩张以及政府和非营利组织的市场准入等因素，北美将在预测期内增长最快. 预计将以高复合年增长率增长。

近期市场趋势

• 2021 年 1 月，Sun Pharmaceutical Industries Ltd. 和 Ferring Pharmaceuticals Pvt. Ltd. 在印度推出了用于预防产后出血的产科药物 CARITEC。
• 2018 年 5 月，辉瑞启动了 Avelumab 的 3 期试验，Avelumab 是一种可与化疗联合使用的卵巢癌药物。 预计这将增加治疗的□□实施并为社区和客户提供一流的护理。

全球女性健康治疗市场报告范围

• 历史数据：2019-2020-2021
• 估算基准年：2021 年
• 预测期：2022-2029
• 报告范围：收入预测、公司排名、竞争格局、增长因素、趋势
• 按地区划分：北美、欧洲、亚太地区、拉丁美洲、世界其他地区
• 定制范围：免费报告定制（最多 8 个工作小时）。 按国家、地区和部门划分的范围的添加和更改。

本研究的目的是弄清近年来各个领域和国家的市场规模，并对未来几年的市场规模进行预测。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还结合了利益相关者投资的潜在微观市场机会，以及主要参与者的竞争格局等详细分析。

内容

第 1 章执行摘要

• 市场概况
• 2019-2029 年各细分市场的全球市场估计和预测
  • 2019-2029 年按地区划分的女性健康治疗市场
  • 女性健康治疗市场，按类型，2019-2029
• 主要趋势
• 调查方法
• 调查先决条件

第 2 章。全球女性健康治疗市场的定义和范围

• 调查目的
• 市场定义和范围
  • 调查范围
  • 工业发展
• 调查年份
• 货币兑换率

第 3 章女性健康疗法的全球市场动态

• 女性健康治疗市场影响分析（2019-2029 年）
  • 市场驱动因素
    • 女性慢性病发病率增加
    • 对预防意外怀孕的避孕药具的需求
  • 市场挑战
    • 昂贵的医疗费用
  • 市场机会
    • 提高对新药疗法的认识并加强介绍
    • 女性传染病患病率高

第 4 章全球女性健康治疗市场行业分析

• 波特 5 力模型
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争公司之间的敌对关係
• 波特 5 力模型的未来方法 (2019-2029)
• 害虫分析
  • 政治
  • 经济的
  • 社交
  • 技术
• 最佳投资机会
• 关键成功策略
• 业内人士的前景
• 分析师的建议和结论

第 5 章风险评估 COVID-19 影响

• 评估 COVID-19 对行业的总体影响
• COVID-19 之前和 COVID-19 之后的市场情景

第 6 章女性健康治疗的全球市场：按类型

• 市场概况
• 全球女性健康治疗市场：按类型、按性能 - 潜力分析
• 2019-2029 年按类型分列的女性保健治疗药物全球市场估计和预测
• 女性健康治疗市场，细分分析
  • 感染
  • 怀孕了
  • 肿瘤学

第 7 章。女性健康治疗的全球市场：区域分析

• 女性健康治疗市场，按地区划分的市场概况
• 北美
  • 美国
    • 2019-2029 年按产品估算和预测
  • 加拿大
• 欧洲女性健康疗法市场概况
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 意大利
  • 其他欧洲
• 亚太地区女性健康疗法市场概况
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 其他亚太地区
• 拉丁美洲女性健康疗法市场概况
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地区
• 世界其他地区

第 8 章衝突信息

• 顶级市场策略
• 公司简介
  • 拜耳公司
    • 关键信息
    • 概览
    • 财务（仅当数据可用时）
    • 产品概览
    • 近期趋势
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • AstraZeneca
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Novartis AG
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd

第9章研究过程

• 研究过程
  • 数据挖掘
  • 分析
  • 市场评估
  • 验证
  • 出版
• 调查的特点
• 调查先决条件

Global Women's Health Therapeutics Market is valued approximately USD 151.33 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.0% over the forecast period 2022-2029. Medical procedures, tools, and services aimed at identifying and enhancing women's health are referred to as therapeutics for women's health. The Women's Health Therapeutics market is expanding because of factors such as growing incidence of chronic health conditions among women, demand for contraceptives to prevent unintended pregnancies. In addition, rising healthcare spending for cancer and infectious disease early detection, pregnancy-related difficulties, and the introduction of new and potent medications are projected to further propel the market.

According to report from world health organization, in 2020, there were 2.3 million women diagnosed with breast cancer which increased from 1.68 million in year 2012. Furthermore, According to a research article by Guttmacher Institute in March 2021, it was estimated that approximately 2.4 million of adolescent women in India want to avoid pregnancy and in need of modern contraception. Thus, the rise in prevalence of cancer and demand for Contraceptives to Prevent Unintended Pregnancies is fostering the market growth. In addition, growing awareness and introduction of new drug therapies, High prevalence of infectious diseases among women is creating a lucrative growth to the market. However, the high cost of Women's Health Therapeutics stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Women's Health Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific dominated the market in terms of revenue, owing to the dominance of branded products, rising target population, rising investment in product development activities. Whereas North America is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

• Bayer AG
• Merck & Co., Inc.
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.
• AstraZeneca
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Novartis AG
• GlaxoSmithKline plc
• F. Hoffmann-La Roche Ltd

Recent Developments in the Market:

• In January 2021, to prevent postpartum bleeding, Sun Pharmaceutical Industries Ltd. and Ferring Pharmaceuticals Pvt. Ltd. launched the obstetric medication CARITEC in India.
• In May 2018, Pfizer initiated a Phase III trial for the ovarian cancer drug Avelumab, which can be used in conjunction with chemotherapy. This is anticipated to increase their treatment offerings and provide communities and customers with top-notch care.

Global Women's Health Therapeutics Market Report Scope:

• Historical Data: 2019-2020-2021

• Base Year for Estimation: 2021

• Forecast period: 2022-2029

• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

• Segments Covered: Type, Region

• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

• Infection
• Pregnancy
• Oncology

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Women's Health Therapeutics Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Women's Health Therapeutics Market, by Type, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Women's Health Therapeutics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Women's Health Therapeutics Market Dynamics

• 3.1. Women's Health Therapeutics Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Growing Incidence of Chronic Health Conditions Among Women
    • 3.1.1.2. Demand for Contraceptives to Prevent Unintended Pregnancies
  • 3.1.2. Market Challenges
    • 3.1.2.1. High cost of therapies
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing awareness and introduction of new drug therapies
    • 3.1.3.2. High prevalence of infectious diseases among women

Chapter 4. Global Women's Health Therapeutics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Women's Health Therapeutics Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Women's Health Therapeutics Market by Type, Performance - Potential Analysis
• 6.3. Global Women's Health Therapeutics Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
• 6.4. Women's Health Therapeutics Market, Sub Segment Analysis
  • 6.4.1. Infection
  • 6.4.2. Pregnancy
  • 6.4.3. Oncology

Chapter 7. Global Women's Health Therapeutics Market, Regional Analysis

• 7.1. Women's Health Therapeutics Market, Regional Market Snapshot
• 7.2. North America Women's Health Therapeutics Market
  • 7.2.1. U.S. Women's Health Therapeutics Market
    • 7.2.1.1. Product breakdown estimates & forecasts, 2019-2029
  • 7.2.2. Canada Women's Health Therapeutics Market
• 7.3. Europe Women's Health Therapeutics Market Snapshot
  • 7.3.1. U.K. Women's Health Therapeutics Market
  • 7.3.2. Germany Women's Health Therapeutics Market
  • 7.3.3. France Women's Health Therapeutics Market
  • 7.3.4. Spain Women's Health Therapeutics Market
  • 7.3.5. Italy Women's Health Therapeutics Market
  • 7.3.6. Rest of Europe Women's Health Therapeutics Market
• 7.4. Asia-Pacific Women's Health Therapeutics Market Snapshot
  • 7.4.1. China Women's Health Therapeutics Market
  • 7.4.2. India Women's Health Therapeutics Market
  • 7.4.3. Japan Women's Health Therapeutics Market
  • 7.4.4. Australia Women's Health Therapeutics Market
  • 7.4.5. South Korea Women's Health Therapeutics Market
  • 7.4.6. Rest of Asia Pacific Women's Health Therapeutics Market
• 7.5. Latin America Women's Health Therapeutics Market Snapshot
  • 7.5.1. Brazil Women's Health Therapeutics Market
  • 7.5.2. Mexico Women's Health Therapeutics Market
  • 7.5.3. Rest of Latin America Women's Health Therapeutics Market
• 7.6. Rest of The World Women's Health Therapeutics Market

Chapter 8. Competitive Intelligence

• 8.1. Top Market Strategies
• 8.2. Company Profiles
  • 8.2.1. Bayer AG
    • 8.2.1.1. Key Information
    • 8.2.1.2. Overview
    • 8.2.1.3. Financial (Subject to Data Availability)
    • 8.2.1.4. Product Summary
    • 8.2.1.5. Recent Developments
  • 8.2.2. Merck & Co., Inc.
  • 8.2.3. Pfizer, Inc.
  • 8.2.4. Teva Pharmaceutical Industries Ltd.
  • 8.2.5. AstraZeneca
  • 8.2.6. Bristol-Myers Squibb Company
  • 8.2.7. Eli Lilly and Company
  • 8.2.8. Novartis AG
  • 8.2.9. GlaxoSmithKline plc
  • 8.2.10. F. Hoffmann-La Roche Ltd

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Women's Health Therapeutics Market, report scope
• TABLE 2. Global Women's Health Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Women's Health Therapeutics Market estimates & forecasts by Product 2019-2029 (USD Billion)
• TABLE 4. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 5. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. U.S. Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 16. U.S. Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. Canada Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 18. Canada Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. UK Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 21. UK Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. Germany Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 24. Germany Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. France Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 27. France Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. Italy Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 30. Italy Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Spain Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 33. Spain Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. RoE Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 36. RoE Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. China Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 39. China Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. India Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 42. India Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. Japan Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 45. Japan Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. South Korea Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 48. South Korea Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. Australia Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 51. Australia Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. RoAPAC Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. Brazil Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 57. Brazil Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Mexico Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 60. Mexico Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. RoLA Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 63. RoLA Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. Row Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 66. Row Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. List of secondary sources, used in the study of global Women's Health Therapeutics Market
• TABLE 69. List of primary sources, used in the study of global Women's Health Therapeutics Market
• TABLE 70. Years considered for the study
• TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Women's Health Therapeutics Market, research methodology
• FIG 2. Global Women's Health Therapeutics Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Women's Health Therapeutics Market, key trends 2021
• FIG 5. Global Women's Health Therapeutics Market, growth prospects 2022-2029
• FIG 6. Global Women's Health Therapeutics Market, porters 5 force model
• FIG 7. Global Women's Health Therapeutics Market, pest analysis
• FIG 8. Global Women's Health Therapeutics Market, value chain analysis
• FIG 9. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Women's Health Therapeutics Market, regional snapshot 2019 & 2029
• FIG 15. North America Women's Health Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Women's Health Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Women's Health Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Women's Health Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 19. Global Women's Health Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable